← Leaderboards
Steven D Goodman
University Of Southern California
$9,840,729
Attributed
$16,489,563
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,489,563 · 9
By mechanism
R01$13,651,829 · 6
R44$2,284,339 · 1
R41$331,395 · 1
U54$222,000 · 1
Top collaborators
- Lauren O Bakaletz10 shared
- Gail E Besner10 shared
- Michael T Bailey9 shared
- Joe Trebley2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Atishay Mathur$108,512
- Dennis M. Deapen$18,403,917
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaMicrobial BiofilmsCommunitiesIn VivoExtracellularIn VitroPreventStructureAnimal ModelHuman DiseasePlayDesignNontypable Haemophilus InfluenzaChronicExtracellular MatrixPathogenInnovationDna-Binding ProteinsBacterial InfectionsDoseAntibodiesBiochemicalAffectChinchilla (Genus)
Grant awards (33)
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment$656,958
R01 · FY2025 · HD
HMGB1-mediated host response to chronic bacterial infection$704,003
R01 · FY2024 · AI · contact PI
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment$683,916
R01 · FY2024 · HD
HMGB1-mediated host response to chronic bacterial infection$720,698
R01 · FY2023 · AI · contact PI
HMGB1-mediated host response to chronic bacterial infection$720,698
R01 · FY2022 · AI · contact PI
HMGB1-mediated host response to chronic bacterial infection$724,279
R01 · FY2021 · AI · contact PI
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1,134,186
R44 · FY2020 · GM
HMGB1-mediated host response to chronic bacterial infection$686,061
R01 · FY2020 · AI · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$574,522
R01 · FY2020 · DC
Tunable Native Probiotic Formulations for the Treatment of NEC.$317,946
R01 · FY2020 · GM
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$1,150,153
R44 · FY2019 · GM
Novel immunotherapeutics for the management of otitis media due to H. influenzae$591,017
R01 · FY2019 · DC
Tunable Native Probiotic Formulations for the Treatment of NEC.$441,859
R01 · FY2019 · GM
Novel immunotherapeutics for the management of otitis media due to H. influenzae$586,252
R01 · FY2018 · DC
Tunable Native Probiotic Formulations for the Treatment of NEC.$522,953
R01 · FY2018 · GM
Novel immunotherapeutics for the management of otitis media due to H. influenzae$577,336
R01 · FY2017 · DC
Tunable Native Probiotic Formulations for the Treatment of NEC.$422,450
R01 · FY2017 · GM
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis$331,395
R41 · FY2017 · GM
Tunable Native Probiotic Formulations for the Treatment of NEC.$65,018
R01 · FY2017 · GM
Novel immunotherapeutics for the management of otitis media due to H. influenzae$610,246
R01 · FY2016 · DC
Novel immunotherapeutics for the management of otitis media due to H. influenzae$455,547
R01 · FY2015 · DC
Novel immunotherapeutics for the management of otitis media due to H. influenzae$477,402
R01 · FY2014 · DC
Novel immunotherapeutics for the management of otitis media due to H. influenzae$460,738
R01 · FY2013 · DC
Novel immunotherapeutics for the management of otitis media due to H. influenzae$563,222
R01 · FY2012 · DC
Novel immunotherapeutics for the management of otitis media due to H. influenzae$495,349
R01 · FY2011 · DC
DYSREGULATION OF THE SICKLE CELL MEMBRANE SKELETON$222,000
U54 · FY2006 · HL · contact PI
Regulation of gtf Gene Expression in S mutans$264,469
R01 · FY2005 · DE
Regulation of gtf Gene Expression in S mutans$264,469
R01 · FY2004 · DE
Regulation of gtf Gene Expression in S mutans$264,469
R01 · FY2003 · DE
Regulation of gtf Gene Expression in S mutans$264,469
R01 · FY2002 · DE
Regulation of gtf Gene Expression in S mutans$264,469
R01 · FY2001 · DE
FUNCTIONAL CHARACTERISTIC OF IHF INDUCED DNA STRUCTURE$137,509
R01 · FY2001 · GM
FUNCTIONAL CHARACTERISTIC OF IHF INDUCED DNA STRUCTURE$133,505
R01 · FY2000 · GM